.jpg)
.jpg)
US FDA approves first drug for fatty liver disease NASH
Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty […] The post US FDA approves first drug for fatty liver disease NASH appeared first on Reuters News Agency.
Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind.
The post US FDA approves first drug for fatty liver disease NASH appeared first on Reuters News Agency.
What's Your Reaction?
.gif)